Pinnacle Financial Group, Inc.’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$240K Hold
2,462
– – 0.02% 426

Other funds holding PBE

Pinnacle Financial Group, Inc.'s PBE Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. reported 2,462 shares of Invesco Biotechnology & Genome ETF (PBE) worth $240K in Q3 2026. The position accounts for 0.02% of the portfolio, ranked #426.

123 funds tracked by Wall St. Rank hold PBE as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 2,462 shares of Invesco Biotechnology & Genome ETF worth $240K as of Q3 2026.
  • Invesco Biotechnology & Genome ETF made up 0.02% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #426 holding.
  • 123 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.